HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 289-300 of 1,979
Drug study icon
CompletedNCT00145470

Safety/Efficacy of Asenapine When Added to Lithium/Valproate for Bipolarity

Official study title

A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Continuing Lithium or Valproic Acid/Divalproex Sodium for the Treatment of an Acute Manic or Mixed Episode

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityMedication studyAges 18+
Countries
Sponsor
Organon and Co
Drug study icon
CompletedNCT00145509

40 Week study to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolarity (A7501009)(P05786)

Official study title

A Phase 3, Placebo-Controlled, Double-Blinded Continuation Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Completing a 12-week Lead-in Trial and Continuing Lithium or Valproic Acid/Divalproex Sodium for the Treatment of an Acute Manic or Mixed Episode

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityMedication studyAges 18+
Countries
Sponsor
Organon and Co
Behavioral study icon
CompletedNCT02893007

A Brief Family-centered Care Program for Bipolarity

Official study title

A Randomized Controlled Trial of a Brief Family-centered Care Program for Hospitalized Patients With Bipolar Disorder and Their Caregivers

This study has finished and is no longer accepting participants.

In Taipei
BipolarityInterventional studyAges 15–65
Countries
Taiwan
Sponsor
Taipei Veterans General Hospital, Taiwan
Drug study icon
CompletedNCT01986114

A Long-Term Study of SM-13496 in people with Bipolarity type I.

Official study title

A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.

This study has finished and is no longer accepting participants.

Multiple locations, including Tokyo
BipolarityMedication studyAges 18–74
Countries
Japan, Lithuania, Malaysia, + 5 others
Sponsor
Sumitomo Pharma Co., Ltd.
Drug study icon
CompletedNCT00277212

Safety and Efficacy of Aripiprazole for Bipolarity

Official study title

A Multicenter, Double-blind, Study of the Efficacy and Safety of Aripiprazole in Combination With Lamotrigine in the Long-term Maintenance Treatment of Patients With Bipolar I Disorder With a Recent Manic or Mixed Episode

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
BipolarityMedication studyAges 18+
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Behavioral study icon
CompletedNCT00330005

A Study of Psychodynamic Psychotherapy for Bipolarity

Official study title

A Pilot Study of Psychodynamic Psychotherapy for Bipolar Disorder

This study has finished and is no longer accepting participants.

In San Antonio
BipolarityBehavioural studyAges 18–75
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.